Patents and Information in Genes: Australia, Policy and the Distinction between DNA and cDNA
Journal Title: Journal of Clinical Trials & Patenting - Year 2016, Vol 1, Issue 1
Abstract
As in the United States, a prohibition on patenting isolated genetic sequences has now been recognized in Australia. On 7 October 2015, the High Court of Australia in D’Arcy v Myriad Genetics Inc., ruled unanimously that an isolated nucleic acid coding for mutant or polymorphic forms of the BRCA1 polypeptide is not a patentable invention [1]. As a consequence, it invalidated Myriad’s BRCA1 patent which claimed an isolated mutated BRCA1 gene sequence.
Authors and Affiliations
Ben McEniery
Keywords
Related Articles
- EP ID EP206910
- DOI 10.13188/2573-3834.1000002
- Views 91
- Downloads 0
Magnesium: Important Role in Medicine & Oncology
Magnesium is an important mineral of our body involved in many human proteins and enzymes of our body. Its deficiency has significant consequences of the health and has been related to many diseases. In this paper I desc...
Perioperative Anxiety
Anxiety is a subjective unpleasant feeling of dread over something unlikely to happen, such as the feeling of imminent death. It is often accompanied by restlessness, fatigue, problems in concentration, and muscular tens...
Innovation in Healthcare Delivery Systems: An Analysis on Burden of Diseases
Health care delivery systems will have to gear up to take up necessary preventive, curative, primitive and rehabilitative healthcare for the population. The challenge of building rural health services, state´s responsibi...
Patent in Biomedicine
Intellectual property is a collective name for the ownership of the results of the human creative mind. Although it refers to intangible property, intellectual property entitles the holder of copyright or patent, tradema...
Patents and Information in Genes: Australia, Policy and the Distinction between DNA and cDNA
As in the United States, a prohibition on patenting isolated genetic sequences has now been recognized in Australia. On 7 October 2015, the High Court of Australia in D’Arcy v Myriad Genetics Inc., ruled unanimously that...